Laryngeal squamous cell carcinoma in HIV-positive patients: Lack of association with human papillomavirus infection

HIV Medicine

Volumn 10, Issue 10, 2009, Pages 634-639

  Moyano, S ^a   Ordi, J ^a   Caballero, M ^a   Garcia, F ^b   Diaz, A ^a   De Sanjose, S ^c,d   Cardesa, A ^a   Alos, L ^a  

^a Department of Pathology ^*  (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

HIV; Human papillomavirus (HPV); Laryngeal carcinoma; Squamous cell carcinoma

Indexed keywords

ABACAVIR; ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DIDANOSINE; EMTRICITABINE; GAG PROTEIN; INDINAVIR; LAMIVUDINE; NEVIRAPINE; PROTEIN P53; RITONAVIR; STAVUDINE; TENOFOVIR; VIRUS DNA; ZIDOVUDINE;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; FEMALE GENITAL TRACT TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNGECTOMY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX RATIO; SQUAMOUS CELL CARCINOMA; VIRUS IDENTIFICATION; WART VIRUS;

ADULT; AGE FACTORS; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, VIRAL; SMOKING;

EID: 70449417807     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00737.x     Document Type: Article

References (27)

1. Castro KG, Ward JW, Slutsker L. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992, 41((RR-17)):1-19.
2. Clifford GM, Polesel J, Rickenbach M. Cancer risk in the Swiss HIV Cohort Study. J Natl Cancer Inst 2005, 97:425-432.
3. Galceran J, Marcos-Gragera R, Soler M. Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer 2007, 43:1085-1091.
4. Demopoulos BP, Vamvakas E, Ehrlich JE, Demopoulos R. Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Arch Pathol Lab Med 2003, 127:589-592.
5. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000, 92:1500-1510.
6. Palefsky J. Human papillomavirus infection in HIV-infected persons. Top HIV Med 2007, 15:130-133.
7. Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 2001, 154:544-556.
8. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007, 90:1-636. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
9. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1. Vaccine 2006, 24S3:S1-S10.
10. Greene FI, Page DL, Fleming ID. AJCC Cancer Staging Manual 2002, eds, 6th edn, Berlin, Springer
11. Cardesa A, Gale N, Nadal A, Zidar N, Barnes L, Eveson JW, Reichart P, Sidransky D. Squamous cell carcinoma. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours 2005, 118-121. In, eds, Lyon, IARC Press
12. Blenke EJ, Clement WA, Andrews JM, Scanlon E, Vernham GA. Squamous cell carcinoma of the larynx in HIV-positive patients. Dysphagia 2007, 22:68-72.
13. Herrero R, Castellsague X, Pawlita M. Human papillomavirus and oral cancer. J Natl Cancer Inst 2003, 95:1772-1783.
14. D'Souza G, Kreimer AR, Viscidi R. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007, 356:1944-1956.
15. Gillison ML, Koch WM, Capone RB. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92:709-720.
16. Harris TG, Burk RD, Xue X. Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women. AIDS 2007, 21:1933-1941.
17. Strickler HD, Palefsky JM, Shah KV. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003, 95:1062-1071.
18. Klaes R, Benner A, Friedrich T. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002, 26:1389-1399.
19. Sidransky D. Molecular genetics of head and neck cancer. Curr Opin Oncol 1995, 7:229-233.
20. Todd R, Donoff RB, Wong DT. The molecular biology of oral carcinogenesis. J Oral Maxillofac Surg 1997, 55:613-623.
21. Klussmann JP, Gultekin E, Weissenborn SJ. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003, 162:747-753.
22. Alos L, Navarrete P, Morente V. Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence. Mod Pathol 2005, 18:127-136.
23. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 2007, 99:962-972.
24. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 2005, 32:527-533.
25. Palefsky JM, Holly EA, Ralston ML. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr 2001, 28:422-428.
26. Bower M, Palmieri C, Dhillon T. AIDS-related malignancies. Curr Opin Infect Dis 2006, 19:14-19.
27. Biggar RJ, Engels EA, Ly S. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 2005, 39:293-299.